Skip to main content

Abstract

HIV can be acquired and transmitted during pregnancy. The adverse outcomes of HIV infection in pregnancy include spontaneous miscarriage, preterm delivery, intrauterine growth restriction, low birth weight and maternal mortality. Another major concern about HIV infection in pregnancy is the risk of transmission of the virus to the baby in utero, during delivery and in the postpartum period through breast milk. There is global call for the elimination of mother-to-child transmission of HIV. The application of current recommendations in the management of HIV-positive pregnant women has resulted in significant reduction in perinatal transmission risk of HIV from the base line value of 25–45% to less than 2% in many developed countries.

This chapter discusses the epidemiology of HIV, risk factors for HIV infection, mother-to-child transmission of HIV, prevention and treatment of HIV infection. The importance of HIV testing and counselling in pregnancy is highlighted. This chapter recommends that persons living with HIV infection should be provided reproductive health services including contraception until her health situation is optimised and safe for pregnancy. This chapter also recommends that all HIV-positive pregnant women should receive professional antenatal, intrapartum and postpartum care. Expert care for the HIV-exposed infant is also recommended for a successful outcome.

Note: Dolutegravir-based regimen should be avoided by women during preconception period and in first trimester of pregnancy due to risk of neural tube defect in their babies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

3TC:

Lamivudine 300 mg OD

ART:

Antiretroviral therapy

ATV/r:

Atazanavir/ritonavir 300 mg + 100 mg

AZT:

Azidothymidine or zidovudine – ZDV 300 mg BD

DRV/r:

Darunavir + ritonavir 800 mg +100 m OD

DTG:

Dolutegravir 50 mg OD

EFV:

Efavirenz 600 mg OD

FTC:

Emtricitabine 200 mg OD

LPV/r:

Lopinavir/ritonavir 400 mg + 100 mg

NRTIs:

Nucleoside reverse transcriptase inhibitors

NVP:

Nevirapine 200 mg OD for 14 days, then 200 mg BD

RAL:

Raltegravir 400 mg OD

TDF:

Tenofovir disoproxil fumarate 300 mg OD

References

  1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic. Geneva: UNAIDS; 2012.

    Google Scholar 

  2. Dabis F, Leroy V, Castetbon K, et al. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000. AIDS. 2000;14:1017–26.

    Article  CAS  PubMed  Google Scholar 

  3. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet. 2002;359:2097–104.

    Article  PubMed  Google Scholar 

  4. Pallela FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60.

    Article  Google Scholar 

  5. Townsend C, Cortina-Borja M, Peckham C, Lyall H, de Ruiter A, Tookey P. Very low risk of mother-to-child transmission of HIV in women on HAART achieving viral suppression in the UK and Ireland. AIDS. 2008;22:973–81.

    Article  PubMed  Google Scholar 

  6. McKenna MT, Hu X. Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol. 2007;197:S10–6.

    Article  PubMed  Google Scholar 

  7. Mahy M, Stover J, Kirigu L, Hayashi C, Akwara P, Luo C, et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect. 2010;86(Suppl 2):ii48–55.

    PubMed  Google Scholar 

  8. Bartlett, JG, Gallant JE. Medical management of HIV infection. 2004th ed. Baltimore: Johns Hopkins Medicine Health Publishing Business Group, 2004.

    Google Scholar 

  9. US Department of Health and Human Services, Health Resources and Services. A guide to the clinical care of women with HIV/AIDS - 2013 edition. Rockville, Maryland. Department of Health and Human Services, Health Resources and Services. 2013. Available at: http://www.hab.hrsa.gov. Accessed 5 July 2016.

  10. World Health Organization. WHO case definition of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, WHO. 2007. Available at: http://www.who.int/hiv/pub/guigelines/HIVstaging150307.pdf. Accessed 5 July 2016.

  11. Agboghoroma OC. Gynaecological and reproductive health issues in HIV-positive women. West Afr J Med. 2010;29(3):135–42.

    CAS  PubMed  Google Scholar 

  12. UNAIDS. Global AIDS update 2016. Global AIDS Response Progress Reporting (GARPR) 2016; UNAIDS 2016 estimates. Available at: http://wwwunaids.org. Accessed on 5 July 2016.

  13. Federal Ministry of Health (FMOH). 2014. National HIV sero-prevalence sentinel survey among pregnant women attending antenatal clinics in Nigeria. Abuja. FMOH; 2015.

    Google Scholar 

  14. National Agency for the Control of AIDS (NACA). Nigeria HIV/AIDS Indicator and Impart Survey (NAIIS): national summary sheet. Abuja. NACA; 2019.

    Google Scholar 

  15. Agboghoroma OC, Giwa-Osagie OF. Infertility management in HIV-positive clients. Afr J Reprod Health. 2012;16(4):13–20.

    PubMed  Google Scholar 

  16. French R, Brocklehurst P. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105:827–35.

    Article  CAS  PubMed  Google Scholar 

  17. Ryder RW, Nsa W, Hassig SE, Behets F, Rayfield M, Ekungola B, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive woman in Zaire. N Engl J Med. 1989;320:1637–42.

    Article  CAS  PubMed  Google Scholar 

  18. Brocklehurst P, French R. The association between maternal HIV – infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105:836–48.

    Article  CAS  PubMed  Google Scholar 

  19. Khan KS, Wojdyia D, Say L, Gulmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systemic review. Lancet. 2006;367:1066–74.

    Article  PubMed  Google Scholar 

  20. The Working Group on Mother – to – Child Transmission of HIV. Rates of mother-to-child transmission of HIV I in Africa, America and Europe: result from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:506–10.

    Article  Google Scholar 

  21. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175–82.

    Article  PubMed  Google Scholar 

  22. Rouzious C, Costagliola D, Burgard M, et al. Estimating timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model: the HIV infection in Newborns French Collaboration Study Group. Am J Epidemiol. 1995;142:1330–7.

    Article  Google Scholar 

  23. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breast-feeding. Lancet. 1992;340:585–8.

    Article  CAS  PubMed  Google Scholar 

  24. Garcia PM, Kalish IA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type I RNA and the risk of perinatal transmission. N Engl J Med. 1999;341:394–420.

    Article  CAS  PubMed  Google Scholar 

  25. British HIV Association. British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV Med. 2014;15(Suppl. 4):1–77.

    Google Scholar 

  26. Dickover R, Garratty E, Plaeger S, Bryson Y. Perinatal transmission of major, minor, and multiple HIV-I strains in Utero and intrapartum. 7th Conf. Retroviruses Opportunistic infect (Abst 181), Jan 30 Feb. 2, 2000.

    Google Scholar 

  27. Reinhardt PP, Reinhardt B, Lathey JL, Spector SA. Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage tropic human immunodeficiency virus type I isolates. J Clin Microbiol. 1995;233:292–7.

    Article  Google Scholar 

  28. Kuhn L, Abrams EJ, Weedon J, et al. Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods. J Infect Dis. 2000;182:104–11.

    Article  CAS  PubMed  Google Scholar 

  29. Nimmagadda A, O’Brien WA, Goetz MB. The significance of vitamin A and carotenoid status in persons infected by the human immunodeficiency virus. Clin Infect Dis. 1998;26:711–8.

    Article  CAS  PubMed  Google Scholar 

  30. Turner BJ, Hauck WW, Fanning R, Markson LE. Cigarette smoking and maternal-child HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:427–37.

    Article  Google Scholar 

  31. Lyman WD. Perinatal AIDS: drugs of abuse and transplacental infection. Adv Exp Med Biol. 1993;335:211–7.

    Article  CAS  PubMed  Google Scholar 

  32. Goldenberg RI, Vermund SH, Geopfert AR, Andrews WW. Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-I transmission? Lancet. 1998;352:1927–30.

    Article  CAS  PubMed  Google Scholar 

  33. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of HIV-I: a meta-analysis from fifteen prospective cohort studies (the International Perinatal HIV Group). N Engl J Med. 1999;340:977–87.

    Article  Google Scholar 

  34. WHO/UNAIDS. HIV in pregnancy: a review WHO/CHS/RHR/99.15 and UNAIDS/99. 35E 1999.

    Google Scholar 

  35. Kostrikis LG, Neumann AU, Thomson B, et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type I to African – American infant. J Virol. 1999;73:10264–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. UNICEF, UNAIDS, WHO. A review of HIV transmission through breast feeding. WHO/FRH/UNT/CHD 98.3 UNAIDS 98.5 UNICEF/PD/NUT (J) 98.3 Geneva 1998.

    Google Scholar 

  37. UNAIDS. Countdown to zero. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva, UNAIDS; 2011.

    Google Scholar 

  38. Federal Ministry of Health. National guidelines for HIV prevention, treatment and care. Abuja: Federal Ministry of Health; 2016.

    Google Scholar 

  39. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. 2nd ed. Geneva: World Health Organization; 2016.

    Google Scholar 

  40. World Health Organization. Updated recommendations on first line and second line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2018.

    Google Scholar 

  41. Cooper E, Charurar M, Burns DN, Blattner W, Hoff R. Trends in antiretroviral therapy and mother-infant transmissioin of HIV. The Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr. 2000;24(1):45–7.

    Article  CAS  PubMed  Google Scholar 

  42. Royal College of Obstetricians and Gynaecologists. Management of HIV in pregnancy. Guideline No. 39, 2004. RCOG, London.

    Google Scholar 

  43. Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):496–505.

    Article  Google Scholar 

  44. Galli L, Puliti D, Chiappini E, et al. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1? Clin Infect Dis. 2009;48(9):1310–7.

    Article  PubMed  Google Scholar 

  45. Agboghoroma OC. Management of HIV in pregnancy: a clinical review. Trop J Obstet Gynaecol. 2005;22(1):65–73.

    Google Scholar 

  46. Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJN, McGrath N, Mwakagile D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes on T-cell counts in HIV-I infected women in Tanzania. Lancet. 1998;351:1477–82.

    Article  CAS  PubMed  Google Scholar 

  47. Ayisi JG, Van Ejik AM, Newman RD, ter Kuile FO, Shi YP, Yang C, et al. Maternal malaria and perinatal HIV transmission. Emerg Infect Dis. 2004;10(4):643–52.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Centres for Disease Control and Prevention. United States Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and Interventions to reduce perinatal HIV-1 transmission in the United States. MMWR 2002;51 (No. RR-18).

    Google Scholar 

  49. van Ham MA, van Dongen PJ, Mulder J. Maternal consequences of caesarean section. A retrospective study of intra-operative and post-operative maternal complications of caesarean section during a 10-year period. Eur J Obstet Gynecol Reprod Biol. 1997;74:1–6.

    Article  PubMed  Google Scholar 

  50. Agboghoroma OC. Contraception in the context of HIV/AIDS. A review. Afr J Reprod Health. 2011;15(3):15–23.

    PubMed  Google Scholar 

  51. World Health Organization. Guidelines on HIV and infant feeding 2010. Geneva: World Health Organization; 2010.

    Google Scholar 

  52. Agboghoroma OC. Prevention of mother-to-child transmission of HIV/AIDS. In: Okonofua FE, editor. Confronting the challenge of reproductive health in Africa: a textbook for students and development practitioners. Benin: WHARC; 2014. p. 345–66.

    Google Scholar 

  53. Donnelly M, Davies JK. Contemporary management of human immunodeficiency virus in pregnancy. In: Swamy GK, Rayburn WF, editors. Obstet Gynaecol Clin North Am Infect Dis Pregnancy. 2014;41(4):547–67.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Agboghoroma, C.O. (2021). HIV in Pregnancy. In: Okonofua, F., Balogun, J.A., Odunsi, K., Chilaka, V.N. (eds) Contemporary Obstetrics and Gynecology for Developing Countries . Springer, Cham. https://doi.org/10.1007/978-3-030-75385-6_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-75385-6_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-75384-9

  • Online ISBN: 978-3-030-75385-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics